Regeneron Pharmaceuticals
REGN
#286
Rank
โ‚น7.390 T
Marketcap
โ‚น69,903
Share price
-2.51%
Change (1 day)
29.24%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): โ‚น457.86 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.34 Billion. , an increase over its 2024 earnings that were of โ‚น452.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น495.64 B9.43%
2024 โ‚น452.92 B13.83%
2023 โ‚น397.91 B-13.57%
2022 โ‚น460.40 B-47.9%
2021 โ‚น883.68 B144.75%
2020 โ‚น361.06 B56.86%
2019 โ‚น230.17 B-4.87%
2018 โ‚น241.96 B22.86%
2017 โ‚น196.95 B56.3%
2016 โ‚น126.00 B8.55%
2015 โ‚น116.08 B54.53%
2014 โ‚น75.12 B11.14%
2013 โ‚น67.59 B72.13%
2012 โ‚น39.26 B-285.93%
2011 -โ‚น21.13 Billion121.73%
2010 -โ‚น9.53 Billion37.18%
2009 -โ‚น6.95 Billion-14.6%
2008 -โ‚น8.14 Billion-25.02%
2007 -โ‚น10.85 Billion6.32%
2006 -โ‚น10.21 Billion-186.52%
2005 โ‚น11.78 B2103.7%
2004 โ‚น0.53 B-105.66%
2003 -โ‚น9.46 Billion-18.18%
2002 -โ‚น11.56 Billion42.33%
2001 -โ‚น8.12 Billion129.35%
2000 -โ‚น3.55 Billion51.87%
1999 -โ‚น2.34 Billion92.19%
1998 -โ‚น1.22 Billion66.23%
1997 -โ‚น0.73 Billion-55.49%
1996 -โ‚น1.64 Billion103.53%
1995 -โ‚น0.81 Billion-70.89%
1994 -โ‚น2.77 Billion-26.08%
1993 -โ‚น3.75 Billion114.67%
1992 -โ‚น1.75 Billion196.77%
1991 -โ‚น0.59 Billion87.88%
1990 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.179 T 541.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.549 T 212.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น850.53 B 71.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น729.56 B 47.19%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น147.48 B-70.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น54.55 B-88.99%๐Ÿ‡บ๐Ÿ‡ธ USA